| Molly Yancovitz, | |
|
243 Charles St, Boston, MA 02114-3002 | |
| (617) 573-3789 | |
| (617) 573-3727 |
| Full Name | Molly Yancovitz |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 20 Years |
| Location | 243 Charles St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265638845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 256929 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beth Israel Deaconess Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc | 4486567104 | 1344 |
News Archive
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
In an effort to bring robotic assistance to workers, the elderly and more, a University of Michigan team is developing a new type of powered exoskeleton for lower limbs—funded by $1.7 million from the National Institutes of Health.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.
› Verified 5 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
In an effort to bring robotic assistance to workers, the elderly and more, a University of Michigan team is developing a new type of powered exoskeleton for lower limbs—funded by $1.7 million from the National Institutes of Health.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.
› Verified 5 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043250616 PECOS PAC ID: 4486567104 Enrollment ID: O20040323000519 |
News Archive
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
In an effort to bring robotic assistance to workers, the elderly and more, a University of Michigan team is developing a new type of powered exoskeleton for lower limbs—funded by $1.7 million from the National Institutes of Health.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.
› Verified 5 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
In an effort to bring robotic assistance to workers, the elderly and more, a University of Michigan team is developing a new type of powered exoskeleton for lower limbs—funded by $1.7 million from the National Institutes of Health.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Molly Yancovitz, 243 Charles St, Boston, MA 02114-3002 Ph: (617) 573-3789 | Molly Yancovitz, 243 Charles St, Boston, MA 02114-3002 Ph: (617) 573-3789 |
News Archive
A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.
In an effort to bring robotic assistance to workers, the elderly and more, a University of Michigan team is developing a new type of powered exoskeleton for lower limbs—funded by $1.7 million from the National Institutes of Health.
Previous studies have indicated that surgeons receive little training in palliative surgical intervention, the objective of which is to relieve symptoms and improve quality of life rather than cure disease or extend survival, according to background information in the article.
Cerner Corporation today announced results for the 2010 second quarter that ended July 3, 2010, delivering strong levels of bookings, revenue, earnings and cash flow.
› Verified 5 days ago
Erica Dommasch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Shapiro 2, Boston, MA 02215 Phone: 617-667-3753 | |
Dr. Chantal Louise Cotter, MB BCH BAO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
Dr. John J Croke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Debjani Sahni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Joseph C Kvedar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Staniford St, Suite 200, Boston, MA 02114 Phone: 617-726-2914 Fax: 617-724-2135 | |
Ryan Char Kelm, Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St # 250, Boston, MA 02114 Phone: 617-724-6960 | |
Dr. David Attar Hashemi, MD, MBA Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St, Boston, MA 02114 Phone: 617-726-2914 |